- Home
- CERS vs AEF Comparison
CERS vs AEF Comparison
Compare CERS & AEF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CERS
- AEF
- Stock Information
- Founded
- CERS 1991
- AEF 1989
- Country
- CERS United States
- AEF United States
- Employees
- CERS N/A
- AEF N/A
- Industry
- CERS EDP Services
- AEF Finance/Investors Services
- Sector
- CERS Technology
- AEF Finance
- Exchange
- CERS Nasdaq
- AEF Nasdaq
- Market Cap
- CERS 276.0M
- AEF 264.3M
- IPO Year
- CERS 1997
- AEF N/A
- Fundamental
- Price
- CERS $1.55
- AEF $6.50
- Analyst Decision
- CERS Strong Buy
- AEF
- Analyst Count
- CERS 2
- AEF 0
- Target Price
- CERS $3.50
- AEF N/A
- AVG Volume (30 Days)
- CERS 1.6M
- AEF 92.5K
- Earning Date
- CERS 10-29-2025
- AEF 01-01-0001
- Dividend Yield
- CERS N/A
- AEF 7.13%
- EPS Growth
- CERS N/A
- AEF N/A
- EPS
- CERS N/A
- AEF 0.57
- Revenue
- CERS $192,510,000.00
- AEF N/A
- Revenue This Year
- CERS $19.07
- AEF N/A
- Revenue Next Year
- CERS $12.03
- AEF N/A
- P/E Ratio
- CERS N/A
- AEF $8.86
- Revenue Growth
- CERS 13.25
- AEF N/A
- 52 Week Low
- CERS $1.12
- AEF $4.40
- 52 Week High
- CERS $2.24
- AEF $5.53
- Technical
- Relative Strength Index (RSI)
- CERS 54.85
- AEF 55.88
- Support Level
- CERS $1.52
- AEF $6.26
- Resistance Level
- CERS $1.70
- AEF $6.58
- Average True Range (ATR)
- CERS 0.10
- AEF 0.10
- MACD
- CERS -0.00
- AEF -0.02
- Stochastic Oscillator
- CERS 46.30
- AEF 65.71
About CERS Cerus Corporation
Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.
About AEF abrdn Emerging Markets Equity Income Fund Inc.
ABERDEEN EMERGING MARKETS EQUITY INCOME FUND, INC. is a closed-end investment company. The Fund's investment objective is to seek to provide both current income and long-term capital appreciation. The Fund invests in a range of sectors, including financials, consumer staples, utilities, consumer discretionary, materials, energy, information technology, private equity, communication services, healthcare, real estate, and industrials.